Teva Pharmaceutical Industries Ltd. (TEVA) vs United Therapeutics Corporation (UTHR)
- Teva Pharmaceutical Industries Ltd. TEVA 41.73 −0.29%
- United Therapeutics Corporation UTHR 564.88 −7.17%
Teva Pharmaceutical Industries Ltd. and United Therapeutics Corporation are both Drug Manufacturers Specialty & Generic companies. Teva Pharmaceutical Industries Ltd. is the larger, with a market value of $48.7B against $24.3B — 2.0× the size. United Therapeutics Corporation trades at the lower P/E: 19.7× against 92.6×. Teva Pharmaceutical Industries Ltd. grew revenue faster over the last twelve months: 2.71% against 1.89%. United Therapeutics Corporation has the higher net margin (38.6% vs 2.94%) and the higher return on invested capital (30.1% vs 4.09%). Across the 22 metrics below, United Therapeutics Corporation leads on 18 and Teva Pharmaceutical Industries Ltd. on 4.
Valuation
Profitability
| Metric | TEVA | UTHR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 53.51% | 86.34% | 53.51% |
| Operating margin | 7.84% | 41.45% | 0.00% |
| Net margin | 2.94% | 38.61% | (2.45%) |
| Free cash flow margin | 7.71% | 27.21% | 0.00% |
| Return on equity | 6.65% | 19.13% | (0.80%) |
| Return on assets | 1.27% | 17.11% | (1.67%) |
| Return on invested capital | 4.09% | 30.13% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack